AN UNBIASED VIEW OF LUCERASTAT

quinupristin/dalfopristin will improve the level or influence of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.quinupristin/dalfopristin will raise the amount or effect of lumateperone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Cut down lumateperone